Abstract:Objectives: Minimally-invasive direct coronary artery bypass (MIDCAB) is a less-invasive alternative to full sternotomy off-pump coronary artery bypass (FS-OPCAB) revascularization of the left anterior descending artery (LAD). Some studies suggested that MIDCAB is associated with a greater risk of graft occlusion and repeat revascularization than FS-OPCAB LIMA-to-LAD grafting. Data comparing MIDCAB to FS-OPCAB with regard to long-term follow-up is scarce. We compared short- and long-term results of MIDCAB vs. FS-OPCAB revascularization over a maximum follow-up period of 10 years. Patients and methods: From December 2009 to June 2020, 388 elective patients were included in our retrospective study. 229 underwent MIDCAB, and 159 underwent FS-OPCAB LIMA-to-LAD grafting. Inverse probability of treatment weighting (IPTW) was used to adjust for selection bias and to estimate treatment effects on short- and long-term outcomes. IPTW-adjusted Kaplan–Meier estimates by study group were calculated for all-cause mortality, stroke, the risk of repeat revascularization and myocardial infarction up to a maximum follow-up of 10 years. Results: MIDCAB patients had less rethoracotomies ( n = 13/3.6% vs. n = 30/8.0%, p = 0.012), fewer transfusions (0.93 units ± 1.83 vs. 1.61 units ± 2.52, p < 0.001), shorter mechanical ventilation time (7.6 ± 4.7 h vs. 12.1 ± 26.4 h, p = 0.005), and needed less hemofiltration ( n = 0/0% vs. n = 8/2.4%, p = 0.004). Thirty-day mortality did not differ significantly between the two groups ( n = 0/0% vs. n = 3/0.8%, p = 0.25). Long-term outcomes did not differ significantly between study groups. In the FS-OPCAB group, the probability of survival at 1, 5, and 10 years was 98.4%, 87.8%, and 71.7%, respectively. In the MIDCAB group, the corresponding values were 98.4%, 87.7%, and 68.7%, respectively (RR1.24, CI0.87–1.86, p = 0.7). In the FS group, the freedom from stroke at 1, 5, and 10 years was 97.0%, 93.0%, and 93.0%, respectively. In the MIDCAB group, the corresponding values were 98.5%, 96.9%, and 94.3%, respectively (RR0.52, CI0.25–1.09, p = 0.06). Freedom from repeat revascularization at 1, 5, and 10 years in the FS-OPCAB group was 92.2%, 84.7%, and 79.5%, respectively. In the MIDCAB group, the corresponding values were 94.8%, 90.2%, and 81.7%, respectively (RR0.73, CI0.47–1.16, p = 0.22). Conclusion: MIDCAB is a safe and efficacious technique and offers comparable long-term results regarding mortality, stroke, repeat revascularization, and freedom from myocardial infarction when compared to FS-OPCAB.

Early Results and Mid-Term Patency of Minimally Invasive Direct Coronary Bypass Grafting Surgery

[The Clinical Effect and Long-Term Follow-Up of Minimally Invasive Direct Coronary Artery Bypass Grafting Via Left Anterior Small Thoracotomy].

Minimally Invasive Direct Coronary Artery Bypass Grafting with an Improved Rib Spreader and a New-Shaped Cardiac Stabilizer: Results of 200 Consecutive Cases in a Single Institution

Minimally Invasive Total Arterial Graft Revascularization Via a Left Minithoracotomy for Multivessel Coronary Artery Dis-Ease

Comparative Study of Minimally Invasive Directly Bypass Grafting With Bilateral Internal Mammary Artery and Conventional Off-pump Bypass Grafting for Treating Multi-vessel Lesion Coronary Artery Disease

Minimally invasive direct coronary artery bypass for left anterior descending artery revascularization - analysis of 300 cases.

Short-Term Clinical Results of Minimally Invasive Direct Coronary Artery Bypass (MIDCAB) Procedure

Early And Mid-Term Results Of Minimally Invasive Direct Coronary Artery Bypass (Midcab) Surgery

A clinical study of minimally invasive left chest incision coronary artery bypass surgery

Comparative Study of Internal Mammary Artery Flow Between Left Minimal Incision and Median Sternotomy in Off-pump Coronary Artery Bypass Grafting

Minimally invasive direct coronary bypass compared with percutaneous coronary intervention for left anterior descending artery disease: a meta-analysis

Minimally Invasive Direct Coronary Artery Bypass after Percutaneous Coronary Intervention.

Experiences and lessons of minimally invasive single coronary artery bypass grafting——505 cases report in asingle institute

Clinical outcome and graft patency of minimally invasive coronary artery bypass grafting for treatment of multi-vessel disease

Off-Pump Onlay-Patch Grafting Using The Left Internal Mammary Artery For A Diffusely Diseased Left Anterior Descending Artery: In-Hospital And Mid-Term Outcomes

Learning Curve of Minimally Invasive Direct Coronary Artery Bypass via Left Anterior Small Thoracotomy

Early and late outcomes after minimally invasive direct coronary artery bypass vs. full sternotomy off-pump coronary artery bypass grafting

Mid-term Graft Patency of Right Versus Left Internal Mammary Artery As Arterial Conduit Usage for Left Anterior Descending Artery Revascularisation: Insights from a Single-Centre Study of Propensity-Matched Data.

Early experience of minimally invasive coronary surgery with bilateral internal mammary artery

In Situ Skeletonized Right Internal Mammary Artery Bypass Grafting to Left Anterior Descending Artery.

Minimally Invasive Coronary Bypass by Using Bilateral Internal Mammary Arteries Combine with Percutaneous Coronary Intervention for Multivessel Coronary Artery Disease:Case Report